For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
First mobile PET-CT scanner in Aotearoa boon for hard-to-reach communities
First mobile PET-CT scanner in Aotearoa boon for hard-to-reach communities

We are on our summer break and the editorial office is closed until 13 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading!
This article was first published on 21 March.
From Zach Thompson: Not sure how this one was all the way back in March (where exactly did the year go?) but it was a great opportunity to be shown the ins and outs of this 44-tonne bus, designed to improve health equity in hard-to-reach areas around Aotearoa. The bus was made possible by the team at Mobile Imaging – a joint venture between Mercy Radiology and Mobile Health Group – and I’m looking forward to seeing what they do next!
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.